Updates and Highlights from OIS@ASRS
The Ophthalmology Innovation Summit (OIS) unites over 500 industry, entrepreneurial, and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs. There are multiple OIS conferences that occur throughout the year; each of which are focused on different areas of ophthalmology. On July 25, 2019, Trial Runners sponsored and attended the OIS@ASRS (American Society of Retina Specialists) conference in Chicago, IL. Trial Runners attendance was represented by Patrick Healy – Chief Development Officer, Brandon Beaudoin – Director of Clinical Development, and Cameron Marshall – Business Development Director. Here is a 2-minute video which nicely summarizes the vision and purpose of OIS – https://vimeo.com/309357865
The meeting was great in providing us with a snapshot of the latest and greatest companies and products being researched in ophthalmology. OIS@ASRS focuses primarily on research being done in the posterior segment (back of the eye). Several products are being developed to help patients with disease indications such as age-related macular degeneration (AMD), diabetic retinopathy and macular edema, and inherited (rare) retinal diseases.
The next OIS conference that TR will be attending is OIS@AAO (American Academy of Ophthalmology) on October 10, 2019 in San Francisco, CA. Wish us luck and stay tuned for an update!